Highlights
NASDAQ: EGRX       Eagle Pharmaceutical
Last Price Today's Change   Day's Range   Trading Volume
57.39   +0.45 (0.79%)  56.575 - 57.90  115,100

Overview

 
Avg Volume (4 weeks):325,484
4 Weeks Range:52.81 - 61.99
4 Weeks Price Volatility (%):
49.89%
52 Weeks Range:45.05 - 97.15
52 Weeks Price Volatility (%):
23.69%
Average Price Target: 65.00
Price Target Upside/Downside: +7.61

Headlines



No recent Headlines for this stock.


Business Background

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The Company's product portfolio includes products, including Argatroban; Ryanodex; docetaxel injection, non-alcohol formulation; and Bendeka. Its advanced candidates include EP-3101 (bendamustine Resistance Temperature Detectors (RTD)) (EP-3101), EP-4104 (dantrolene sodium for exertional heat stroke (EHS)) (EP-4104), EGL-4104-C-1702 (dantrolene sodium for drug induced hyperthermia), EP-5101 (pemetrexed) (EP-5101) and EGL-5385-C-1701 (fulvestrant). Its product portfolio focuses on oncology, critical care and orphan diseases. Bendamustine is an alkylating agent approved for use in chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin's lymphoma (NHL), that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

  Be the first to like this.
 


 

3136  4051  767  443 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMD 13.41-0.33 
 BAC 25.16+0.10 
 GE 24.75+0.43 
 XLF 25.46+0.06 
 SPY 249.39-0.67 
 VALE 10.32-0.27 
 F 11.72+0.01 
 GDX 23.21-0.29 
 SDRL 0.371-0.107 
 AAPL 153.39-2.68 
Partners & Brokers